Rising Cost of Antimalarial Medicine: SBM Highlights Need for Urgent Treatment Alternatives
Favour Ozioma Ogbodo Worried about the increase in antimalarial medicines, SBM Intelligence had called for provision of safe cheaper alternatives for treating malaria. In August 2023, GlaxoSmithKline, a British Pharmaceutical company, announced the end of its 51-years old business in Nigeria. This was barely 3 months after Sanofi, also announced plans of their exit. SBM…